Clinical Trials Directory

Trials / Completed

CompletedNCT03383744

Using Stable Isotopes to Assess the Effectiveness of Vitamin A Supplementation in Cameroon

Using Stable Isotope Techniques to Monitor and Assess the Vitamin A Status of Children Susceptible to Infection

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
104 (actual)
Sponsor
Centre for Food and Nutrition Research, Yaounde · Other Government
Sex
All
Age
3 Years – 5 Years
Healthy volunteers
Not accepted

Summary

This is a study to evaluate the effects of vitamin A supplementation program on the vitamin A status of preschool children. All children aged 3-5 years who do not have severe illness and are not planning to move from the study area are eligible. Children whose caregivers agree to sign the consent form will be enrolled in their community and submitted to a longitudinal evaluation of vitamin A status before and after vitamin A supplementation campaign. Vitamin A status will be assessed by measuring serum retinol, retinol binding protein and vitamin A total body pool size using stable isotope dilution methodology.

Detailed description

Five months after the last supplementation (day 0), an oral dose (2 mg retinol equivalents) of label vitamin A (\[2H8\]-retinyl acetate) in oil will be administered to 80 eligible children together with a low vitamin A high-fat snack. Fasting venous blood samples (about 7 ml) will be collected into evacuated foil-wrapped blood collection tubes specifically designed for the collection of serum (containing no anticoagulant and metal free) on the mornings of days 0 before the administration of the dose and on day 14 for quantitative estimation of initial vitamin A pool size and determination of potential confounding parameters (CRP, AGP, iron, zinc, malaria, carotenoids and retinoids). About six months after the last supplementation (day 30), each child will received the vitamin A supplement. After 30 days and 90 days, two groups of 40 children (Grp1, Grp2) will respectively received a second dose of labeled vitamin A (\[2H4\]-retinyl acetate); fasting venous blood samples will be obtained before the administration of the dose and 14 days after dosing for quantitative estimation of final vitamin A pool size and determination of potential confounding parameters.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTvitamin A supplementationEach child received one capsule of 200,000 IU of vitamin A

Timeline

Start date
2015-10-05
Primary completion
2016-03-23
Completion
2016-07-29
First posted
2017-12-26
Last updated
2017-12-26

Source: ClinicalTrials.gov record NCT03383744. Inclusion in this directory is not an endorsement.